Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ: MASI )

168.21 +2.52 (+1.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Apple’s Market Maneuvers: Is AAPL Stock a Smart Buy at $193?
A ban on the Apple Watch could hit AAPL stock hard as the wearable is the tech stock's second biggest money-maker 
Via InvestorPlace
How A Late-Night Email To Tim Cook 10 Years Ago Possibly Triggered Masimo's Battle To Get Apple Watch Banned
In 2013, a scientist named Marcelo Lamego fired off an email to Cook, pitching a vision that could propel Apple to the forefront of the medical, fitness, and wellness market, Bloomberg reported. 
Via Benzinga
US Stocks Pause, Gold Rises As Dollar, Treasury Yields Fall: What's Driving Markets Wednesday?
The U.S. stock market experienced a quiet day on Wednesday, with major indices showing minimal movement amid typical year-end low volume activity. The S&P 500 hovered around 4,777 points, remaining... 
Via Benzinga
Apple Wins Temporary Reprieve in Watch Import Ban Over Masimo's Pulse Oximetry Patent Row
On Wednesday, a U.S. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Recap: Masimo Q3 Earnings
Via Benzinga
What 7 Analyst Ratings Have To Say About Masimo
Via Benzinga
Apple Pauses Watch Sale Due to Technology Dispute. What Should You Do With the Stock?
Apple must halt its Apple Watch sales before Dec. 25. 
Via The Motley Fool
Apple Appeals Against Smartwatch Sales Ban After White House Declines To Interfere
Apple appeals against a smartwatch sales ban, filing for court review after the White House declines involvement in the U.S. International Trade Commission's imposed restriction due to a patent dispute... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse
From threats to its smartwatch operations to a significant increase in its card savings interest rate, let's delve into the Apple-centric news that unfolded this past week. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dow Jones Giants Apple, Microsoft Lead Five Stocks Near Buy Points
Investors should keep tabs on these five stocks trading tightly. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute
Masimo CEO Joe Kiani has expressed willingness to settle the ongoing patent dispute with Apple related to the Apple Watch Ultra 2 and Apple Watch Series 9, saying that the tech giant has not initiated... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Shares of Masimo Are Dropping Tuesday
The company's preliminary second-quarter numbers have investors worried. 
Via The Motley Fool
Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban?
The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report
Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,... 
Via Benzinga
Topics ETFs
Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know
Via Benzinga
Robinhood, eBay, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Big Tech Earnings, Results From a Couple of Financial Companies, and a Look at Spotify
We also chat with author Michael Lewis about Sam Bankman-Fried. 
Via The Motley Fool
Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI)  
Via Benzinga
Masimo Surges After Winning A Potential $100 Million Battle Against Apple
Federal officials say Apple violated patent laws in its Apple Watch. 
Via Investor's Business Daily
Topics Intellectual Property
Exposures Intellectual Property
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Nasdaq, S&P 500 Eye Rebound While Bitcoin Edges Down: Amazon's Q3 Lifts Tech Stocks As Traders Eye Fed's Favorite Inflation Gauge
As Amazon, Inc. (NASDAQ:AMZN) hawked good tidings, the negative sentiment in the equity market appears to have reversed. The recovery could be in part due to traders looking for bargains following a... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Apple's Timepiece Trouble: Patent Dispute Puts Apple Watch Imports in Jeopardy
The U.S. International Trade Commission may ban the import of Apple Watches due to a patent infringement dispute with medical tech firm Masimo, pending a presidential review and potential appeals. 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Disney's Lost Decade and Next Act
The market's had a surprisingly strong 2023, but investors might be eying easy low-risk yields elsewhere. 
Via The Motley Fool
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
Via Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77.... 
Via Benzinga
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.